terclim by ICS banner
IVES 9 IVES Conference Series 9 OIV 9 OIV 2024 9 Orals - Safety and health 9 Pharmacological basis of the J-shaped curve in biological effects of wine

Pharmacological basis of the J-shaped curve in biological effects of wine

Abstract

The classical pharmacological model assumes that the effect of a drug is proportional to the fraction of receptors occupied by the drug. In the simplest circumstances, the relationship between dose of a drug and response, when plotted on a logarithmic scale for drug concentration, is described by a sigmoidal curve. It presumes the existence of a threshold dose, below which no biological effect appears, and a maximal response in the form of a plateau, when a further increase in the dose of drug has no effect. In this mathematical  concept, however, exceptions are quite common, and different  theories and models have been proposed to explain those exceptions.  In contrast to the standard pharmacological model, in real life it is commonly seen that different compounds exhibit opposite effects as a function of dosage.  The phenomenon of small quantities having effects opposite from that of large quantities is commonly termed “hormesis”. The hormetic type of dose-response relationship may be described as an inverted U-shaped or a J-shaped dose response. Whether the dose response is an inverted u- or j-shape is determined by the endpoint that is measured.  In the context of human nutrition, the hormetic biphasic effects of alcohol consumption on human health has been particularly well studied.  In the case of wine, there are two principal constituents that are considered responsible for the majority of wines’ biological effects: alcohol and phenolic compounds. On the example of results from two different experimental models with different endpoints, it will be shown in this presentation, that both alcohol and wine phenolics obey the hormetic biphasic dose-response relationship. This corresponds well with the epidemiological finding of the J-shaped dose-response association of wine consumption with different diseases and total mortality.

Pharmakologische grundlage der J-förmigen kurve in den biologischen wirkungen von wein

Das klassische pharmakologische modell geht davon aus, dass die wirkung eines arzneimittels proportional zum anteil der vom arzneimittel besetzten rezeptoren ist. Im einfachsten fall wird die beziehung zwischen der dosis eines arzneimittels und seiner reaktion, wenn es auf einer logarithmischen skala für die arzneimittelkonzentration aufgetragen wird, durch eine sigmoidkurve beschrieben. Es geht davon aus, dass es eine schwellendosis gibt, unterhalb derer keine biologische wirkung auftritt, und eine maximale reaktion in form eines plateaus, bei dem eine weitere erhöhung der arzneimitteldosis keine wirkung zeigt. In diesem mathematischen konzept gibt es jedoch recht häufig ausnahmen, und zur erklärung dieser ausnahmen wurden unterschiedliche theorien und modelle vorgeschlagen. Im gegensatz zum pharmakologischen standardmodell zeigt sich im wirklichen leben häufig, dass verschiedene verbindungen je nach dosierung gegensätzliche wirkungen zeigen. Das phänomen, dass kleine mengen entgegengesetzte wirkungen wie große mengen haben, wird allgemein als „hormesis“ bezeichnet. Die hormetische art der dosis-wirkungs-beziehung kann als eine umgekehrt u-förmige oder j-förmige dosis-wirkungs-beziehung beschrieben werden. Ob die dosisreaktion eine umgekehrte u- oder j-form hat, wird durch den gemessenen endpunkt bestimmt. Im kontext der menschlichen ernährung sind die hormetischen biphasischen auswirkungen des alkoholkonsums auf die menschliche gesundheit besonders gut untersucht. Im fall von wein gibt es zwei hauptbestandteile, die für die meisten biologischen wirkungen von weinen verantwortlich sind: alkohol und phenolische verbindungen. Am beispiel der ergebnisse zweier unterschiedlicher versuchsmodelle mit unterschiedlichen endpunkten wird in diesem vortrag gezeigt, dass sowohl alkohol- als auch weinphenole der hormetischen biphasischen dosis-wirkungs-beziehung gehorchen. Dies entspricht gut dem epidemiologischen befund des j-förmigen dosis-wirkungs-zusammenhangs von weinkonsum mit verschiedenen krankheiten und der gesamtmortalität.

Basi farmacologiche della curva J negli effetti biologici del vino

Il modello farmacologico classico presuppone che l’effetto di un farmaco sia proporzionale alla frazione di recettori occupati dal farmaco. Nelle circostanze più semplici, la relazione tra la dose di un farmaco e la sua risposta, quando rappresentata su una scala logaritmica per la concentrazione del farmaco, è descritta da una curva sigmoidale. Si presuppone l’esistenza di una dose soglia, al di sotto della quale non si manifesta alcun effetto biologico, e una risposta massima sotto forma di plateau, quando un ulteriore aumento della dose del farmaco non ha alcun effetto. In questo concetto matematico, tuttavia, le eccezioni sono abbastanza comuni e sono state proposte diverse teorie e modelli per spiegare tali eccezioni. Contrariamente al modello farmacologico standard, nella vita reale si osserva comunemente che diversi composti mostrano effetti opposti in funzione del dosaggio. Il fenomeno delle piccole quantità che hanno effetti opposti a quello delle grandi quantità viene comunemente chiamato “ormesi”.  Il tipo ormetico della relazione dose-risposta può essere descritto come una risposta alla dose a forma di U invertita o a forma di J. Se la risposta alla dose è a forma di u invertita o di J è determinato dall’endpoint misurato. Nel contesto della nutrizione umana, gli effetti ormetici bifasici del consumo di alcol sulla salute umana sono stati particolarmente studiati. Nel caso del vino, sono due i principali costituenti considerati responsabili della maggior parte degli effetti biologici del vino: l’alcol e i composti fenolici. Utilizzando l’esempio dei risultati di due diversi modelli sperimentali con endpoint diversi, in questa presentazione verrà mostrato che sia i composti fenolici dell’alcol che quelli del vino obbediscono alla relazione ormetica bifasica dose-risposta. Ciò corrisponde bene con il risultato epidemiologico dell’associazione dose-risposta a forma di J del consumo di vino con diverse malattie e mortalità totale.

Publication date: November 18, 2024

Issue: OIV 2024

Type: Article

Authors

Mladen Boban¹

¹ University of Split, School of Medicine, Šoltanska 2, Split, Croatia

Contact the author*

Tags

IVES Conference Series | OIV | OIV 2024

Citation

Related articles…

Genomic comparison on O. oeni: can l. hilgardii be a novel starter culture in malolactic fermentation?

Malolactic fermentation (MLF) the microbial bioconversion of L-malic acid into L-lactic acid, is a pivotal metabolic process that holds fundamental significance for the quality and organoleptic characteristics of some wines. Oenococcus oeni is considered to be the main player in this conversion, and it is globally used as a starter culture for mlf thanks to his capacity to tolerate the harsh wine environment.

A new winemaking technology: fermentation, aging and bottling without added additives and preservatives

Auric infinity Technology introduces three new patented products designated for fermentation, aging and bottling without added additives and preservatives that have never been used in the winemaking industry.

Training system and its influence on iso-anisohydric behavior of cv. Syrah

Water use efficiency is one of the most valued objectives in vine growing in mediterranean climates (de la fuente et al., 2015). Due to this, the grape growers provide different adaptation strategies according to their efficient consumption against the presumable water deficit generated under these environmental conditions. The use of non-positioned shoot systems (like sprawl, bush, etc.) Can help to achieve this objective.

Determination of steviol glycosides in wine by HPLC

The SCL laboratory in Bordeaux is one of the two official control laboratories for wine and wine products in france, under the authority of the ministry of finance and two of its general directorates: the DGCCRF (directorate general for competition, consumer affairs and fraud control) and the DGDDI (directorate general of customs and excise duties). In this capacity, it verifies the regulatory compliance of wines and investigates any possible falsifications or fraud. Steviol glycosides are natural sweeteners that are not authorized as additives in wine.

High pressure homogenization of wine lees. A tool to streamline the management of wine ageing

Aging on lees (AOL) has been used for wine aging for a long time, thanks to its ability to modify wine composition, improving sensory characteristics and stability. However, the prolonged contact with fermentation lees may increase the risk of developing sensory defects, due to the growth of unwanted microorganisms. Furthermore, AOL requires a large amount of work to manage bâtonnage and for topping up the barrels, significantly increasing production costs.